Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evolutionary Genomics is a biotechnology company specializing in the identification of high-value genes through its proprietary AdaptedTraits platform. The company utilizes advanced molecular evolution analysis to pinpoint genes that have undergone positive selection, suggesting they play a critical role in specific biological traits. This technology is applied across both agricultural biotechnology, for traits like crop yield and pest resistance, and human health, for target discovery in infectious diseases and oncology. Evolutionary Genomics operates primarily as a discovery-stage partner, licensing its identified genetic targets to larger pharmaceutical and agricultural firms for further development. Their unique approach allows for the rapid identification of functional genes that traditional genomic methods might overlook.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evolutionary Genomics.